|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Non-Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Parallel Assignment; Masking: Open Label; Primary Purpose: Treatment |
| Conditions: |
Rotator Cuff Arthropathy Failed Total Shoulder Failed Hemi-arthroplasty |
| Intervention: |
Device: Reverse Shoulder Prosthesis |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| Primary | Subjects who are eligible to receive a reverse shoulder prosthesis and who have not previously received another orthopedic implant in the operative shoulder. |
| Revision | Subjects who are eligible to receive a reverse shoulder prosthesis and who have previously received another orthopedic implant in the operative shoulder. The change in implant device is due to failure of the previously inserted orthopedic device. |
| Continued Access | Subjects who are eligible to receive a reverse shoulder prosthesis and who have not previously received another orthopedic implant in the operative shoulder. This group are also primary subjects who were enrolled at a later date in order to collect additional data on the reverse shoulder. |
| Primary | Revision | Continued Access | |
|---|---|---|---|
| STARTED | 141 | 141 | 234 |
| COMPLETED | 75 | 71 | 131 |
| NOT COMPLETED | 66 | 70 | 103 |
| Death | 12 | 6 | 13 |
| Revision of Device | 12 | 23 | 14 |
| Physician Decision | 1 | 0 | 0 |
| Withdrawal by Subject | 1 | 7 | 4 |
| Lost to Follow-up | 40 | 34 | 72 |
Baseline Characteristics
| Description | |
|---|---|
| Primary | Subjects who are eligible to receive a reverse shoulder prosthesis and who have not previously received another orthopedic implant in the operative shoulder. |
| Revision | Subjects who are eligible to receive a reverse shoulder prosthesis and who have previously received another orthopedic implant in the operative shoulder. The change in implant device is due to failure of the previously inserted orthopedic device. |
| Continued Access | Subjects who are eligible to receive a reverse shoulder prosthesis and who have not previously received another orthopedic implant in the operative shoulder. This group are also primary subjects who were enrolled at a later date in order to collect additional data on the reverse shoulder. |
| Primary | Revision | Continued Access | Total | |
|---|---|---|---|---|
|
Number of Participants
[units: participants] |
141 | 141 | 234 | 516 |
|
Age
[units: participants] |
||||
| <=18 years | 0 | 0 | 0 | 0 |
| Between 18 and 65 years | 30 | 52 | 57 | 139 |
| >=65 years | 111 | 89 | 177 | 377 |
|
Age
[units: years] Mean ± Standard Deviation |
71.9 ± 9.5 | 67.4 ± 11.6 | 71.2 ± 9.2 | 70.4 ± 10.1 |
|
Gender
[units: participants] |
||||
| Female | 87 | 97 | 136 | 320 |
| Male | 54 | 44 | 98 | 196 |
|
Region of Enrollment
[units: participants] |
||||
| United States | 141 | 141 | 234 | 516 |
|
Operative Shoulder
[units: participants] |
||||
| Right | 87 | 83 | 146 | 316 |
| Left | 54 | 58 | 88 | 200 |
Outcome Measures
| 1. Primary: | American Shoulder and Elbow Surgeons Shoulder Score [ Time Frame: 2-year ] |
| 2. Primary: | Average Range of Motion [ Time Frame: 2-year ] |
| 3. Primary: | Subject Satisfaction With Surgery [ Time Frame: 2-year ] |
| 4. Primary: | Have Surgery Again? [ Time Frame: 2-year ] |
| 5. Primary: | Neer's "Limited Goals" [ Time Frame: 2-year ] |
| 6. Primary: | Radiographic Failures [ Time Frame: Post-operative, 3-month, 6-month, 1-year, 2-year ] |
| 7. Primary: | Safety Assessment [ Time Frame: 2-year ] |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. | ||||||
| There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. | ||||||
The agreement is:
|
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Jane M. Jacob Ph.D., DJO Surgical |
| ClinicalTrials.gov Identifier: | NCT00764504 History of Changes |
| Other Study ID Numbers: | Study 300 |
| Study First Received: | September 30, 2008 |
| Results First Received: | November 19, 2010 |
| Last Updated: | March 21, 2011 |
| Health Authority: | United States: Food and Drug Administration |